英文原著論文 "2023" Original Papers in English


緑色のタイトル部分をクリックすると、論文PDFが表示されます。

【 2023 年 】(IF: 2022 年)

  1. Satoh T, Yaoita N, Nochioka K, Tatebe S, Hayashi H, Yamamoto S, Sato H, Takahama H, Suzuki H, Terui Y, Yamada K, Yamada Y, Inoue T, Aoki T, Satoh K, Sugimura K, Miyata S, Yasuda S. Inhaled nitric oxide testing in predicting prognosis in pulmonary hypertension due to left-sided heart diseases. ESC Heart Fail. 2023 Dec;10(6):3592-3603. doi: 10.1002/ehf2.14515. Epub 2023 Sep 29.

  2. Okubo N, Sugawara S, Fujiwara T, Sakatsume K, Doman T, Yamashita M, Goto K, Tateishi M, Suzuki M, Shirakawa R, Eura Y, Kokame K, Hayakawa M, Matsumoto M, Kawate Y, Miura M, Takiguchi H, Soga Y, Shirai S, Ando K, Arai Y, Nakayoshi T, Fukumoto Y, Takahama H, Yasuda S, Tamura T, Watanabe S, Kimura T, Yaoita N, Shimokawa H, Saiki Y, Kaikita K, Tsujita K, Yoshii S, Nakase H, Fujimaki S, Horiuchi H. VWF:RCo/VWF: Ag for diagnosis of acquired von Willebrand syndrome caused by aortic stenosis. Thromb Haemost. (in press) (IF=6.7)

  3. Kubota H, Masato Tsutsui M, Kuniyoshi K, Yamashita H, Shimokawa H, Sugahara K, Kakinohana M. Alleviated cerebral infarction in male mice lacking all nitric oxide synthase isoforms after middle cerebral artery occlusion. J Anesthesia. DOI: 10.1007/s00540-023-03271-8 (IF=2.8)

  4. Takeuchi M, Suzuki H, Miyata S, Ebihara S, Yasuda S. Angina, a preoperative clinical sign for the development of delirium after transcatheter aortic valve implantation Geriatrics & Gerontology International (in press) (IF=3.3)

  5. Nochioka K, Shiroto T, Hayashi H, Inoue T, Oyama K, Susukita K, Takahama H, Takahashi J, Shimokawa H, Yasuda S. Long-term prognostic significance of history of cancer and atrial fibrillation in coronary artery disease. Int J Cardiol Heart & Vasculature. (in press) (IF=2.9)

  6. Satoh T, Yaoita N, Nochioka K, Tatebe S, Hayashi H, Yamamoto S, Sato H, Takahama H, Suzuki H, Terui Y, Yamada K, Yamada Y, Inoue T, Aoki T, Satoh K, Sugimura K, Miyata S, Yasuda S. Inhaled nitric oxide testing in predicting prognosis in pulmonary hypertension due to left-sided heart diseases. ESC Heart Fail. 2023 Sep 29. doi:10.1002/ehf2.14515. Online ahead of print. PMID: 37775984 (IF=3.8)

  7. Nochioka K, Kato S, Pileggi G, Horii K, Shiroto T, Shimokawa H, Yasuda S. Serial assessment of cardiothoracic ratio as a predictor of progression from stage B to stage C heart failure in asymptomatic patients with cardiac diseases. Int J Cardiol Heart & Vasculature 2023 Sep 17;48:101273. doi: 10.1016/j.ijcha.2023.101273. (IF=2.9)

  8. Terui Y, Suzuki H, Chikata A, Hanaki Y, Komatsu Y, Ota H, Fujishima F, Umezawa R, Ouchi K, Sato H, Satoh T, Miyamichi-Yamamoto S, Yaoita N, Hayashi H, Nochioka K, Takahama H, Nogami A, Saiki Y, Yasuda S. Intractable ventricular tachycardia prior to overt cardiac tumor mass of metastatic cardiac rhabdomyosarcoma (spindle-cell type) Internal Medicine. 2023 (in press) (IF=1.2)

  9. Shimizu W, Uchiyama S, Atarashi H, Inoue H, Kitazono T, Yamashita T, Ikeda T, Kamouchi M, Kaikita K, Fukuda K, Origasa H, Shimokawa H. Effectiveness and safety of reduced-dose rivaroxaban for elderly patients with non-valvular atrial fibrillation: a subanalysis of the EXPAND study. Int J Cardiol. (in press) (IF=3.5)

  10. Tatebe S, Yasuda S, Konno R, Sakata Y, Sugimura K, Satoh K, Shiroto T, Miyata S, Adachi O, Kimura M, Mizuno Y, Enomoto J, Tateno S, Nakajima H, Oyama K, Saiki Y, Shimokawa H. Clinical and sociodemographic factors associated with health-related quality of life in patients with adult congenital heart disease: A nationwide cross-sectional multicenter study. Circ J. Advance Publication DOI:10.1253/circj.CJ-23-0383 (IF=3.3)

  11. Kamiya K, Takei M, Nagai T, Miyoshi T, Ito H, Fukumoto Y, Obara H, Kakuma T, Sakuma I, Daida H, Iimuro S, Shimokawa H, Kimura T, Nagai R, Anzai T, the REAL-CAD study investigators. Association between non-lipid residual risk factors and cardiovascular events in patients with stable coronary artery disease treated with pitavastatin: An observation from the REAL-CAD Study. J Atheroscler Thromb. (in press)(IF=4.4)

  12. Mitsutake Y, Ishii J, Fukumoto Y, Ito S, Kashiwabara K, Uemura K, Matsuyama Y, Sugiyama Y, Ozaki Y, Iimuro S, Iwata H, Sakuma I, Nakagawa Y, Hibi K, Hiro T, Hokimoto S, Miyauchi K, Daida H, Shimokawa H, Saito Y, Kimura T, Matsuzaki M, Nagai R. PDifferential prediction of high-sensitivity cardiac troponin-I, but not N-terminal pro-brain natriuretic peptide, in different pitavastatin doses on cardiovascular events in stable coronary artery disease. Int J Cardiol. 2023 Jun 22;131138. doi: 10.1016/j.ijcard.2023.131138. (Online ahead of print) (IF=3.5)

  13. Higuma T, Akashi YJ, Fukumoto Y, Obara H, Kakuma T, Asaumi Y, Yasuda S, Sakuma I, Daida H, Shimokawa H, Kimura T, Iimuro S, Nagai R. Residual coronary risk factors associated with long-term clinical outcomes in patients with coronary artery disease treated with high- versus low-dose statin therapy: REAL-CAD sub-study. Circ J. (in press) (IF=3.3)

  14. Shindo T, Ito K, Ogata T, Kurosawa R, Eguchi K, Kagaya Y, Hanawa K, Hasebe Y, Nishimiya K, Shiroto T, Takahashi J, Okumura Y, Noguchi T, Ozaki Y, Daida H, Hagiwara N, Masuyama T, Chikamori T, Fukumoto Y, Tsujita K, Kanai H, Yasuda S, Shimokawa H. A randomized, double-blind, placebo-controlled pilot trial of low-intensity pulsed ultrasound therapy for refractory angina pectoris. PLOS ONE 2023 Jun 23;18(6):e0287714. doi: 10.1371/journal.pone.0287714. (eCollection 2023) (IF=3.7)

  15. Nakamura M, Tamaru S, Hirooka S, Hirayama A, Tsuji A, Hirata M, Munemasa M, Nakagawa I, Toshima M, Shimokawa H, Nishimura Y, Ogura T, Yamamoto T, Satokawa H, Obayashi T, Yamada N; AKAFUJI Study Investigators. Efficacy and safety of warfarin for the treatment of venous thromboembolism: a multicenter prospective observational cohort study in Japan (AKAFUJI Study). Circ J. (in press) (IF=3.3)

  16. Morinaga J, Kashiwabara K, Torigoe D, Okadome Y, Aizawa K, Uemura K, Kurashima A, Matsunaga E, Fukami H, Horiguchi H, Sato M, Sugizaki T, Miyata K, Kadomatsu T, Mukoyama M, Miyauchi K, Hokimoto S, Fukumoto Y, Hiro T, Hibi K, Nakagawa Y, Sakuma I, Ozaki Y, Iwata H, Iimuro S, Daida H, Shimokawa H, Kimura T, Matsuzaki M, Saito Y, Matsuyama Y, Nagai R, Oike Y. Plasma ANGPTL8 levels and risk for secondary cardiovascular events in Japanese patients with stable coronary artery disease receiving statin therapy. Arterioscler Thromb Vasc Biol. 2023 Jun 1. doi: 10.1161/ATVBAHA.122.318880. (Online ahead of print) (IF=8.7)

  17. Ohyama-Tamagake A, Kaneko K, Itami R, Nakano M, Namioka Y, Izumi R, Sato H, Suzuki H, Takeda A, Okazaki Y, Yatsuka Y, Abe T, Murayama K, Sugeno N, Misu T and Aoki M. Adult-onset Leigh syndrome with a m.9176 T>C mutation manifested as reversible cerebral vasoconstriction syndrome. Internal Medicine 2022 Dec 21. doi: 10.2169/internalmedicine.0773-22. (Online ahead of print) (IF=1.2)

  18. Takahama H, Nishimura K, Ahsan B, Hamatani Y, Makino Y, Nakagawa S, Irie Y, Moriuchi K, Amano M, Okada A, Kitai T, Amaki M, Kanzaki H, Noguchi T, Kusano K, Akao M, Yasuda S, Izumi C. Clinical application of artificial intelligence algorithm for prediction of one-year mortality in heart failure patients. Heart and Vessels 2023 Jun;38(6):785-792. doi: 10.1007/s00380-023-02237-w. (Epub 2023 Feb 20) (IF=1.5)

  19. Nakagawa S, Takahama H, Hoshino K, Yanagi Y, Irie Y, Moriuchi K, Amano M, Okada A, Amaki M, Kanzaki H, Kusano K, Noguchi T, Yasuda S, Izumi C. Prevalence and predictive factors for clinical outcomes of isolated functional tricuspid regurgitation. J Cardiol. 2022 Dec 21;S0914-5087(22)00325-2. doi: 10.1016/j.jjcc.2022.12.008. (Online ahead of print) (IF=2.5)

  20. Nakano K, Nochioka K, Yasuda S, Tamori D, Shiroto T, Sato Y, Takaya E, Miyata S, Kawakami E, Ishikawa T, Ueda T, Shimokawa H. Machine learning approach to stratify complex heterogeneity of chronic heart failure: A report from the CHART-2 Study. ESC Heart Fail. 10:1597–1604,2023. (IF=3.8)

  21. Kimura S, Kawamorita N, Ishizuka Y, Satake Y, Sato T, Izumi H, Shimokawa H, Ito A. Low-energy shock wave therapy ameliorates ischemic-induced overactive bladder in a rat model. Sci Rep. 2022;12:21960. DOI: 10.1038/s41598-022-26292 (IF=4.6)

  22. Fukui K, Takahashi J, Hao K, Honda S, Nishihara K, Kojima S, Takegami M, Sakata Y, Itoh T, Watanabe T, Takayama M, Sumiyoshi T, Kimura K, Yasuda S; on behalf of the JAMIR Investigators. Disparity of Performance Measure by Door-to-Balloon Time between Rural and Urban Area for Management of Patients with ST-Segment Elevation Myocardial Infarction -Insights from the Nationwide Japan Acute Myocardial Infarction Registry- Circ J 2023 Apr 25;87(5):648-656. doi: 10.1253/circj.CJ-22-0454. (Epub 2022 Dec 2) (IF=3.3)

  23. Terui Y, Sugimura K, Ota H, Tada H, Nochioka K, Sato H, Katsuta Y, Fujiwara J, Harada-Shoji N, Sato-Tadano A, Morita Y, Sun W, Higuchi S, Tatebe S, Fukui S, Miyamichi-Yamamoto S, Suzuki H, Yaoita N, Kikuchi N, Sakota M, Miyata S, Sakata Y, Ishida T, Takase K, Yasuda S, Shimokawa H. Usefulness of cardiac magnetic resonance for early detection of cancer therapeutics-related cardiac dysfunction in breast cancer patients. Int J Cardiol. 2023;371:472-479. (IF=3.5)

  24. Nakata T, Shindo T, Ito K, Eguchi K, Monma Y, Ichijo S, Ryoke R, Satoh W, Kumasaka K, Satoh H, Kurosawa R, Satoh K, Kawashima R, Miura M, Kanai H, Yasuda S, Shimokawa H. Beneficial effects of low-intensity pulsed ultrasound therapy on right ventricular dysfunction in animal models. JACC: Basic Trans Sci. 8(3):283–297,2023. DOI: 10.1016/j.jacbts.2022.08.010 (IF=9.7)